Biocon, Mylan win patent violation suit filed by Sanofi in US over insulin glargine device

Biopharmaceutical firm Biocon on March 11 said its partner Mylan has won a US court ruling that invalidated a Sanofi patent on an insulin glargine device.

https://www.moneycontrol.com/news/business/companies/biocon-mylan-win-patent-violation-suit-filed-by-sanofi-in-us-over-insulin-glargine-device-5023301.html